Found this...
Recent research suggests dandelion root extract may have anti-cancer properties, including potential benefits in treating chronic myeloid leukemia (CML). Specifically, studies have shown that dandelion root extract can induce apoptosis (programmed cell death) in leukemia cells, particularly in chronic myelomonocytic leukemia (CMML) cell lines. While these findings are promising, more research is needed to fully understand the efficacy and mechanisms of action in in-vivo models and human patients.
Key findings from research on dandelion and CML:
Apoptosis induction:
Dandelion root extract has been shown to trigger apoptosis in leukemia cells, including those of CMML, a type of leukemia.
Cancer cell selectivity:
Some studies indicate that the extract's effects on apoptosis are selective, meaning it targets cancer cells without harming healthy cells.
Potential for combination therapy:
Research suggests that dandelion root extract could be used in combination with conventional treatments like chemotherapy to potentially enhance their effectiveness and reduce tumor cell populations.
Case study evidence:
A case study documented a patient with CMML who experienced improved hematological parameters and reduced bone marrow blast counts while using dandelion root extract.
